114 related articles for article (PubMed ID: 2727085)
1. Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages.
Lynch DH; Haddad S; King VJ; Ott MJ; Straight RC; Jolles CJ
Photochem Photobiol; 1989 Apr; 49(4):453-8. PubMed ID: 2727085
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the immunosuppression induced by cutaneous photodynamic therapy: persistence, antigen specificity and cell type involved.
Musser DA; Oseroff AR
Photochem Photobiol; 2001 May; 73(5):518-24. PubMed ID: 11367574
[TBL] [Abstract][Full Text] [Related]
3. IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response.
Gollnick SO; Musser DA; Oseroff AR; Vaughan L; Owczarczak B; Henderson BW
Photochem Photobiol; 2001 Dec; 74(6):811-6. PubMed ID: 11783937
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressive effects of phthalocyanine photodynamic therapy in mice are mediated by CD4+ and CD8+ T cells and can be adoptively transferred to naive recipients.
Yusuf N; Katiyar SK; Elmets CA
Photochem Photobiol; 2008; 84(2):366-70. PubMed ID: 18208456
[TBL] [Abstract][Full Text] [Related]
5. Systemic immunosuppression induced by peritoneal photodynamic therapy.
Jolles CJ; Ott MJ; Straight RC; Lynch DH
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 1):1446-53. PubMed ID: 2968047
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik M; Dougherty GJ
Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.
Korbelik M; Naraparaju VR; Yamamoto N
Br J Cancer; 1997; 75(2):202-7. PubMed ID: 9010027
[TBL] [Abstract][Full Text] [Related]
8. Studies on the role of antigen-presenting cells in the systemic suppression of contact hypersensitivity by UVB radiation.
Kripke ML; McClendon E
J Immunol; 1986 Jul; 137(2):443-7. PubMed ID: 3088101
[TBL] [Abstract][Full Text] [Related]
9. Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes.
Kobayashi H; Aso H; Ishida N; Maeda H; Pollard RB; Suzuki F
Cell Immunol; 1990 Jul; 128(2):589-602. PubMed ID: 2162738
[TBL] [Abstract][Full Text] [Related]
10. Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy.
Korbelik M; Krosl G
Photochem Photobiol; 1994 Nov; 60(5):497-502. PubMed ID: 7800721
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells.
Schwarz A; Grabbe S; Mahnke K; Riemann H; Luger TA; Wysocka M; Trinchieri G; Schwarz T
J Invest Dermatol; 1998 Mar; 110(3):272-6. PubMed ID: 9506448
[TBL] [Abstract][Full Text] [Related]
12. Systemic suppression of the contact hypersensitivity by the products of protoporphyrin IX photooxidation.
Kyagova AA; Mansurova GV; Kozir LA; Ponomarev GV; Pavlov VY; Konstantinov IO; Potapenko AY
Photochem Photobiol; 2005; 81(6):1380-5. PubMed ID: 16080780
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
Hayami J; Okamoto H; Sugihara A; Horio T
J Dermatol; 2007 May; 34(5):320-7. PubMed ID: 17408441
[TBL] [Abstract][Full Text] [Related]
14. Enhanced skin allograft survival after photodynamic therapy. Association with lymphocyte inactivation and macrophage stimulation.
Qin B; Selman SH; Payne KM; Keck RW; Metzger DW
Transplantation; 1993 Dec; 56(6):1481-6. PubMed ID: 8279023
[TBL] [Abstract][Full Text] [Related]
15. Selective suppression of host T cell and macrophage activities during 7,12-dimethylbenz[a]anthracene-induced carcinogenesis.
Yamashita U; Hamaoka T
Gan; 1982 Oct; 73(5):773-82. PubMed ID: 6219909
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
Chow KP; Battisto JR
J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
[TBL] [Abstract][Full Text] [Related]
17. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy.
Ferrario A; Gomer CJ
Cancer Res; 1990 Feb; 50(3):539-43. PubMed ID: 2137023
[TBL] [Abstract][Full Text] [Related]
18. New method of immunosuppression by selective destruction of CTL by a photodynamic effect.
Satomi S; Sakurada M; Morimoto K; Satake M; Ohtsuki S; Takeda Y; Amada N; Taguchi Y; Mori S
Transplant Proc; 1989 Feb; 21(1 Pt 1):1134-6. PubMed ID: 2650078
[No Abstract] [Full Text] [Related]
19. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
Shand FL
Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
[TBL] [Abstract][Full Text] [Related]
20. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
Cecic I; Stott B; Korbelik M
Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
